News on Medial

Related News

Varco Leg Care raises $500K in Seed funding

EntrackrEntrackr · 1y ago
Varco Leg Care raises $500K in Seed funding
Medial

Delhi-based leg care brand Varco Leg Care has raised $500,000 (over Rs 4.5 crore) in Seed funding round led by Sunicon Maiden Fund, an early-stage venture fund curated by Sunicon Ventures. Prior to this, Varco Leg Care had raised a cumulative Rs 3.1 crore ($370,000) through its previous funding rounds. According to the company, its valuation has grown by 2x in the past 10 months. However, it did not disclose the numbers. Varco Leg Care will be utilizing the capital to strategically bolster capabilities across various fronts, which include enhancing offline touchpoints, advancing research and development (R&D) initiatives, and scaling and optimizing marketing efforts. Varco Leg Care aims to revolutionise leg health management by leveraging technology and clinical expertise. The firm has created a wide range of leg care products that address the end-to-end leg health needs of customers worldwide targeting health issues like varicose veins, diabetic foot, foot ulcer, and restless leg syndrome, among others. As per the company, it saw 110% increase in the brand’s revenue over the past year. Since its inception in 2022, Varco claims to have served more than 5 lakh customers, and expanded its presence to more than 3,000 medical stores across Mumbai, Bangalore, Delhi, and other Indian cities. Varco’s products are available at organised retail outlets such as Guardian Pharmacy, Noble Plus, Wellness Forever, and others. On the online front, it sells its products through its own website, as well as via marketplaces like Amazon, Flipkart, 1mg, and others.

Neuroscience startup BrainSight AI raises $5 Mn

EntrackrEntrackr · 6m ago
Neuroscience startup BrainSight AI raises $5 Mn
Medial

Snippets Neuroscience startup BrainSight AI raises $5 Mn Deep-tech neuroscience startup BrainSight AI has raised $5 million in a pre-Series A funding round led by IAN Alpha Fund, along with participation from IvyCap Ventures, Silver Needle, and its existing investors. The fresh funds will be utilized to expand its presence in India, increasing reach in Tier I and Tier II cities, making a foray into Africa, Southeast Asia, the US, and allied markets, and enhancing R&D capabilities, BrainSight said in a press release. Co-founded in 2019 by Laina Emmanuel and Rimjhim Agrawal, BrainSight AI aims to enable greater precision in the diagnosis and treatment planning of neuro-oncological and neuropsychiatric disorders. The platform combines artificial intelligence and neuroscience to enable precision in neurological and psychiatric investigations for accelerated patient outcomes. According to BrainSight, its platform products include Voxelbox, which provides clinicians with access to an fMRI processing engine and machine-learning models; and Snowdrop, a patient care app that enables compliance with treatment schedules and builds patient profiles. Currently, BrainSight AI asserts that it collaborates with over 40 leading hospitals across India, particularly in neurosurgery and radiology departments, focusing on brain tumor cases. The company is now expanding its solutions to neurological and psychiatric disorders, paving the way for a more holistic approach to brain care. BrainSight AI helps to understand how the physiology of the brain correlates to its functions by mapping macro-scale neural connections in the brain to enable precise diagnosis and prognosis of neuro-oncological and neuropsychiatric disorders.

Download the medial app to read full posts, comements and news.